Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study

BACKGROUND: Mirogabalin, which is approved for the treatment of peripheral neuropathic pain in Japan, is a ligand for the α2δ subunit of voltage-gated calcium channels. Both pregabalin and mirogabalin act as nonselective ligands at the α2δ-1 and α2δ-2 subunits. Mirogabalin has a unique binding profi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Orthop Surg Res
Autors principals: Tetsunaga, Tomoko, Tetsunaga, Tomonori, Nishida, Keiichiro, Misawa, Haruo, Takigawa, Tomoyuki, Yamane, Kentaro, Tsuji, Hironori, Takei, Yoshitaka, Ozaki, Toshifumi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249688/
https://ncbi.nlm.nih.gov/pubmed/32456647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13018-020-01709-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars